Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection

  • Mayte Coiras, Juan Ambrosioni, Francisco Cervantes, José M. Miró, José Alcamí
  • Expert Opinion on Drug Safety, April 2017, Taylor & Francis
  • DOI: 10.1080/14740338.2017.1313224

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14740338.2017.1313224